Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10064	Companies
205720	Keywords
135960	Articles
109067	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 02/25/2025 at 07:00, 1 year ago

Biophytis annonce sa participation au 15ème Congrès International sur la Fragilité et la Sarcopénie (ICFSR)
Biophytis participera au 15ème Congrès ICFSR pour présenter BIO101 dans la sarcopénie associée à l’obésité. La société de biotechnologie se concentre sur le développement de traitements pour les maladies liées à l'âge

Biophytis Sarcopénie Maladies Liées À L'âge Obésité Congrès ICFSR
REGULATED PRESS RELEASE

published on 02/25/2025 at 07:00, 1 year ago

Biophytis announces its participation in the 15th International Conference on Frailty and Sarcopenia Research (ICFSR)
Biophytis to participate in ICFSR 15th International Conference on Frailty and Sarcopenia Research, presenting data on BIO101 for obesity-associated sarcopenia. Event in Toulouse, March 12-14

Biophytis Sarcopenia ICFSR BIO101 Obesity
BRIEF

published on 02/11/2025 at 07:05, 1 year 1 month ago

Biophytis annonce ses priorités stratégiques pour 2025

Biophytis Partenariats Stratégie 2025 Sarcopénie Obésité
BRIEF

published on 02/11/2025 at 07:05, 1 year 1 month ago

Biophytis Outlines 2025 Strategic Plans

Strategic Partnerships Biophytis Clinical Development Obesity Treatment Sarcopenia
REGULATED PRESS RELEASE

published on 02/11/2025 at 07:00, 1 year 1 month ago

Biophytis dévoile ses perspectives stratégiques de l’année 2025
Biophytis dévoile ses perspectives stratégiques pour l’année 2025, incluant le lancement de nouveaux programmes cliniques et des collaborations clés dans le domaine des maladies liées à l'âge

Stratégie Biophytis Partenariats Développement Clinique Maladies Liées À L'âge
REGULATED PRESS RELEASE

published on 02/11/2025 at 07:00, 1 year 1 month ago

Biophytis unveils its outlook strategies for 2025
Biophytis unveils its strategic outlook for 2025, focusing on clinical development and commercialization plans for BIO101 (20-Hydroxyecdysone) in obesity and sarcopenia, with key partnerships and agreements

Biophytis Clinical Development BIO101 Obesity Strategic Outlook
BRIEF

published on 01/27/2025 at 07:05, 1 year 1 month ago

Biophytis to Participate in BIOMED FORUM Investor Conference

Biophytis Investor Conference Healthcare Sector Paris BIOMED Forum
BRIEF

published on 01/27/2025 at 07:05, 1 year 1 month ago

Biophytis participe à la conférence Biomed Forum à Paris

Biophytis Biotechnologie Investisseurs BIOMED Forum Santé
REGULATED PRESS RELEASE

published on 01/27/2025 at 07:00, 1 year 1 month ago

Biophytis announces its participation to the BIOMED FORUM investor conference
Biophytis announces participation in Biomed Forum investor conference to engage with investors and share updates on developments for age-related diseases

Biophytis Investor Conference Healthcare Sector BIOMED Forum Age-related Diseases
REGULATED PRESS RELEASE

published on 01/27/2025 at 07:00, 1 year 1 month ago

Biophytis annonce sa participation à la conférence investisseurs BIOMED FORUM
Biophytis annonce sa participation à la conférence investisseurs BIOMED FORUM, occasion de rencontrer des investisseurs pour présenter les avancées et perspectives 2025

Biophytis Biotechnologie Investisseurs BIOMED Forum Conference

Accesswire

Published on 03/23/2026 at 12:32, 9 minutes ago

Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 11 minutes ago

Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 12:30, 11 minutes ago

High Tide Resources Announces Closing of Concurrent Non-Brokered Private Placements for Gross Proceeds of $8.3 Million
Published on 03/23/2026 at 12:20, 21 minutes ago

Guanajuato Silver Adds Veteran Mine Operator to Board of Directors
Published on 03/23/2026 at 12:15, 26 minutes ago

Snipp Interactive Secures US$3 Million Contract, Largest in Company History

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 12:33, 8 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 03/23/2026 at 12:29, 12 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 03/23/2026 at 11:44, 57 minutes ago

Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology
Published on 03/23/2026 at 11:30, 1 hour 11 minutes ago

EQS Group lance un module de gestion des risques pour faciliter la surveillance continue des risques liées aux données et à l’IA
Published on 03/23/2026 at 11:06, 1 hour 34 minutes ago

Aroundtown SA: Release of a capital market information

Les Echos

Published on 03/23/2026 at 08:10, 4 hours 31 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 17 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 17 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 18 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 18 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE